Farringdon Capital’s CVS Health CVS Stock Holding History

Farringdon Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,542	Closed	-$569K	–	476
2025 Q3	$569K	Buy	+7,542	New	+$517K	0.14%	210

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Farringdon Capital's CVS Position: Q4 2025 in Review

Farringdon Capital sold out of CVS Health (CVS) in Q4 2025, closing a stake of 7,542 shares — an estimated $569K sold.

Farringdon Capital first reported a position in CVS in Q3 2025 and held it in 1 quarter. The position peaked at $569K in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

Farringdon Capital reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
Farringdon Capital sold 7,542 CVS Health shares in Q4 2025, an estimated $569K.
Farringdon Capital first reported a position in CVS Health in Q3 2025 and held it in 1 quarter.
Farringdon Capital's CVS Health position peaked at $569K in Q3 2025.
1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.